Salute e Benessere

INDIAWOOD 2025: Quarter Century of Driving Innovation in Indian Woodworking and…

Since its inception in 2000, INDIAWOOD has grown exponentially, beginning at R.B.A.N.M.'s Grounds, transitioning to Palace Grounds, and finding its current home at the Bangalore International Exhibition Centre (BIEC) in 2008. The event has continually evolved, mirroring the dynamic nature of the industry. The upcoming edition will feature 600 exhibitors and is expected to attract over 30,000 visitors from across 1,200 cities, a remarkable increase from the 294 cities in 2002. Since its...
PR Newswire
31/07/2024

Pertussis Treatment Market Projected to Hit US$ 5.3 Billion by 2034, with a 3.4%…

Pertussis, also known as whooping cough, is an infectious respiratory disease caused by the Bordetella pertussis bacteria. Pertussis mostly affects young children and the older population, and treatment involves medication, vaccination, and supportive care. Pertussis, also known as whooping cough, is an infectious respiratory disease caused by the Bordetella pertussis bacteria. Pertussis mostly affects young children and the older population, and treatment involves medication, vaccination…
PR Newswire
31/07/2024

Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval

In recent years, the Chinese pharmaceutical industry has embarked on a significant expansion into international markets. But actually, Kexing Biopharm began its international ventures 20 years ago with its core products. In recent years, the company has introduced more than a dozen high-quality Chinese medications to emerging markets, improving accessibility to medicines for local patients. In recent years, the Chinese pharmaceutical industry has embarked on a significant expansion into...
PR Newswire
31/07/2024

Furniture Market to Reach $840.5 Billion, Globally, by 2034 at 4% CAGR: Allied…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/5147 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/5147 Prime determinants of growth The growth of the furniture market is fueled by increased demand for residential and commercial furniture as populations migrate to cities. Rising disposable incomes enable consumers to invest in quality furniture, while changing lifestyle preferences...
PR Newswire
31/07/2024

Foresters Financial celebrates 150 years by donating to a member-selected…

Launched in 1977, the Tuberous Sclerosis Association (TSA) supports people living with TSC. This rare genetic disorder causes non-cancerous tumors in various organs, including the brain, skin, kidneys, heart, and lungs with symptoms varying from learning difficulties, seizures, and developmental delays. There is currently no cure, but treatment can manage symptoms and improve quality of life. Launched in 1977, the Tuberous Sclerosis Association (TSA) supports people living with TSC. This rare...
PR Newswire
31/07/2024

Essity spearheads menstrual health in partnership with the World Economic Forum

Essity's Chief Strategy Officer, Sahil Tesfu, has joined the Community of Champions of the Forum's Global Alliance for Women's Health. The Community of Champions is a collective of global leaders and advocates committed to prioritizing, protecting and promoting the health of women and closing the women's health gap. Essity's Chief Strategy Officer,Sahil Tesfu, has joined the Community of Champions of the Forum's Global Alliance for Women's Health. The Community of Champions is a collective...
PR Newswire
31/07/2024

Avance Clinical Announces Senior Appointment to North American Operations

Avance Clinical, an award-winning, mid-sized full-service global Contract Research Organization (CRO) for biotech companies, is pleased to announce the appointment of Jeanne Schow as Senior Vice President, Business Development. Jeanne will be based out of theSan Francisco Bay Area. Meet Jeanne Schow and the Avance Clinical North American team at the next biotech event.Book a Meeting Here.Yvonne Lungershausen, CEO of Avance Clinical, expressed her enthusiasm about Jeanne's...
Nasdaq GlobeNewswire
31/07/2024

Groupe Casino: RELEASE OF THE HALF YEAR 2024 RESULTS PRESENTATION

The Group has released its half year 2024 results presentation on its website. It is available at this link: https://www.groupe-casino.fr/wp-content/uploads/2024/07/20240731-Presentation-H1-2024-EN.pdf Analyst and investor contactsChristopher Welton+33 (0)1 53 65 64 [email protected] Charlotte Izabel+33 (0)1 53 70 51 [email protected] Relations+33 (0)1 53 65 24 [email protected] Press...
Nasdaq GlobeNewswire
31/07/2024

PureHealth Achieves AED 1.0 billion Net Profit in 1H 2024; EBITDA Soars to AED…

Revenue from Hospitals grew 83% y-o-y to AED 9.6 billion in H1 2024, primarily driven by the contributions generated from the Group's acquisitions of Sheikh Shakhbout Medical City (SSMC) and Circle Health Group during the period. The segment's revenue was also supported by higher patient volumes (OP up 17% y-o-y, IP up 43% y-o-y, and ED up 43% y-o-y)1 along with an 11% increase in overall bed occupancy to 72%, as well as the addition of the National Rehabilitation Center (NRC) to PureHealth's…
PR Newswire
31/07/2024

Santhera Appoints Dr. Oliver P. Kronenberg as Chief Legal Officer and Company…

Dr. Kronenberg brings 25 years of legal experience, with 20 years in the pharmaceutical industry Oliver Strub appointed as Head of CompliancePratteln, Switzerland, July 31, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces the Board of Directors has appointed Dr. Oliver P. Kronenberg as Chief Legal Officer and Corporate Secretary of Santhera Pharmaceuticals AG, effective August 1, 2024. As a member of the executive management team, Dr. Oliver P. Kronenberg will lead the...
Nasdaq GlobeNewswire
31/07/2024

DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for…

DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “Company”), today announced the filing, for the semester ended June 30, 2024, of its Half-Year Report with the French market...
Nasdaq GlobeNewswire
30/07/2024

Long-term lecanemab data show increased patient benefit with maintained safety…

Highlights of the presentations included: Highlights of the presentations included: "Long-term data for lecanemab which our partner Eisai has presented today are very impressive. It shows that the patient benefit of lecanemab continues to increase over time, which is exactly what is expected from a disease modifying treatment. In addition, the safety profile continues to be in line with what we saw in the phase three study," saidGunilla Osswald, CEO at BioArctic. "It is also…
PR Newswire
30/07/2024

DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and…

DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut allergic 4-7-year-olds is on-track and recruitment is expected to be complete by end of Q3 2024 DBV submitted a labeling proposal, informed by the EPITOPE efficacy data, to the Food and Drug Administration (FDA) to address the FDA's protocol queries regarding patch wear-time in COMFORT ToddlersDBV...
Nasdaq GlobeNewswire
30/07/2024

Diamyd Medical Announces Positive Interim Analysis Results for Phase 3 Trial in…

The interim analysis evaluated six-month data from 74 patients enrolled in the trial, assessing the likelihood of the trial achieving one of its co-primary endpoints, specifically the preservation of endogenous insulin-producing capacity measured as stimulated C-peptide. The DSMB's recommendation is based on the data observed to date, indicating that the trial is on track and has the potential to meet its objectives. The interim analysis evaluated six-month data from 74 patients enrolled in…
PR Newswire
30/07/2024

IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2024

AggregatedpresentationbydayandbymarketPurchases of own shares from July 22th to 26th, 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1122/07/2024FR00102591504 826110,5421XPARIPSEN549300M6SGDPB4Z94P11...
Nasdaq GlobeNewswire
30/07/2024

Casino Group: Press release - H1 2024

FIRST-HALF 2024 The transformation of the New Casino is underway Financial results downgraded by a damaging legacy and the context of restructuringRestructuring projects well under wayStreamlining of the store network: closures, conversions to franchises and rational expansionSale of hypermarkets and supermarkets, the main source of the Group's historic lossesReorganisation of the Group's head offices and logistics at Distribution Casino FranceAgreement to sell Codim...
Nasdaq GlobeNewswire
30/07/2024

H1 2024 Results - Focus-27 strategic plan on track with timely execution of the…

Press Release Paris, 30th July 2024 Net Sales down 9.6% year-on-year – Core EBITDA margin at 10.6%Accelerated commercial momentum with clients other than Sanofi, with Net Sales up 2.9%, excluding the Brindisi site, where production was temporarily suspendedEnhanced effectiveness across the entire organization, with sizeable improvements in industrial efficiencies€10 million Free Cash Flow before financing, driven by strengthened financial disciplineFY 2024...
Nasdaq GlobeNewswire
30/07/2024

eClinical Solutions Market worth $22.1 billion by 2029 driven by Rising Chronic…

Browse in-depth TOC on "eClinical Solutions Market"317 - Tables54 - Figures244 - Pages Browse in-depth TOC on "eClinical Solutions Market" 317 - Tables 54 - Figures 244 - Pages Medidata (A Dassault Systèmes Company): Leader in End-to-End Clinical Data Management Medidata excels in global clinical data capture and management with extensive functionality tailored for diverse clinical study needs. The company's robust market position is reinforced by its comprehensive organic...
PR Newswire
30/07/2024

Digital Health Market to Reach USD 881 Billion in 2031 on the Back of Growing…

Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/digital-health-market Digital Health Market Overview: Segments covered in Digital Health Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/digital-health-market Enhanced Internet Connectivity Estimated to Boost Demand for Digital Health for Telehealth Technology Growing penetration of digital...
PR Newswire
30/07/2024

Biosimilars Market Likely to Attain Valuation of USD 92 Billion by 2031 As…

Download a detailed overview:https://www.skyquestt.com/sample-request/biosimilars-market Download a detailed overview: https://www.skyquestt.com/sample-request/biosimilars-market Biosimilars Market Overview: Segments covered in Biosimilars Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/biosimilars-market Oncology Projected to Spearhead Biosimilar Demand Owing to Increasing Need for Novel Cancer Treatments...
PR Newswire
30/07/2024

Dental Membrane and Bone Graft Substitutes Market to Reach US$ 1.3 Billion by…

The dental membrane and bone graft substitutes market stood at US$ 650.8 Mn in 2022 and is expected to record a CAGR of 7.7% from 2023 to 2031, as per Transparency Market Research (TMR). The dental membrane and bone graft substitutes market stood at US$ 650.8 Mn in 2022 and is expected to record aCAGR of 7.7%from2023 to 2031, as perTransparency Market Research (TMR). Bone grafting is a surgical procedure practiced to repair lost or damaged bones that are located below...
PR Newswire
30/07/2024

Sustainable Beauty and Skincare Market will Expand USD 326.8 Billion to 2031-…

The clean beauty movement places the highest premium on sustainability, safety, and transparency in the skincare industry. People can take better care of their physical appearance and have a smaller environmental impact when they appreciate clean beauty. Everyone may contribute to the sustainable beauty revolution in the future, which promises to be a fascinating time of inventions and improvements. The clean beauty movement places the highest premium on sustainability, safety, and…
PR Newswire
30/07/2024

Nocturia Market to Reach US$ 8.5 Billion by 2034, Fueled by the Integration of…

A significant trend is the increased focus on patient-centric care. Healthcare providers and pharmaceutical companies are prioritizing patient education and support programs to enhance understanding and management of nocturia. This approach aims to improve treatment adherence and patient outcomes by empowering individuals with the knowledge and tools to manage their condition effectively. A significant trend is the increased focus on patient-centric care. Healthcare providers and…
PR Newswire
30/07/2024

Connext Successfully Administers First Dose of CNT201 for Dupuytren's…

Dupuytren's contracture is a debilitating condition characterized by the fibrosis of the fascia between the skin and tendons of the palm due to collagen buildup, causing fingers to become permanently bent and significantly impairing patients' quality of life. Currently, there is no fundamental cure for this condition. Treatments primarily involve surgical interventions like fasciectomy to alleviate symptoms, although non-surgical methods, such as localized injections of collagenase, have shown…
PR Newswire
30/07/2024
Altri  Comunicati